## Session overview The after-midnight session featured modest but broad two-sided action, with ZTS leading gainers near four percent while UPS slumped over four percent to pace losers. Salesforce remained under pressure as Benioff defended the company's

Verdict: Wait for optimization — entry rules have never fired

**Verdict: Wait for parameter optimization** This oversold-momentum reversal screen is not yet a tradeable signal. The fundamental backdrop is genuinely bifurcated: the idea's long basket includes high-quality cash generators like Salesforce (CRM), with a 77.7% gross margin and $14.4B in free cash flow (99th percentile in tech), alongside deeply stressed names like Boeing (BA), which carries a 4.8% gross margin (6th percentile in Industrials) and negative $1.9B in free cash flow (dead last among 454 industrial peers). Similarly, Citigroup (C) shows negative $74.2B in free cash flow (bottom percentile among Financials) and an ROE of just 6.7% (38th percentile), diluting the quality of any long-biased reversal watch list. Per the Yahoo Finance piece on CRM, Marc Benioff is defending the AI strategy even as the stock has fallen over 30% in 2026, which could support an oversold recovery thesis if technical conditions align. The structural barrier, however, is that the entry rules have not triggered a single trade across 1,214 daily bars over 60 months. The binding constraint is a stochastic crossover requirement (crossing above exactly zero) that the research author identifies as mathematically near-impossible, since stochastic oscillators almost never reach absolute zero. Although bounded optimization was requested to loosen this threshold, no robust parameter setup was established before the time budget was exceeded. Currently, the RSI condition is met on six of the ten symbols (BA at 35.2, C at 29.4, CRM at 29.3, CVS at 26.5, UPS at 22.0, and ZTS at 34.4, all below the 45 cutoff), but the full condition stack cannot complete without a rule revision. **Conviction Breakdown** - **Thesis support: 45** — The underlying oversold-reversal thesis has merit for high-quality names like CRM and ZTS (78.3% ROE, 90th percentile in Health Care), but the inclusion of distressed names like BA and contracting names like UPS (revenue down 2.6% year-over-year, 23rd percentile for growth) weakens the fundamental foundation. - **Trade readiness: 15** — The strategy cannot be executed as designed. Zero triggers across 60 months means the rules are fundamentally broken, not just dormant. - **Risk quality: 30** — The theoretical 2:1 reward-to-risk ratio is undermined by extreme individual-name risk: ZTS delivered −46.0% annualized returns with a 63.4% max drawdown and deeply negative skew of −4.3, while BSX posted a 60.6% drawdown. The risk-parity framework's reliance on T for stability (18.4% weight) raises concentration concerns. - **Trigger proximity: 10** — The stochastic-zero crossover condition has never been satisfied and remains far from triggering. No symbol meets the full condition stack, and the price ceiling of 77.26 is far from met for BA (232.15), C (133.85), CRM (185.13), and CVS (96.20). - **Fundamentals trend: 50** — Fundamentals are highly dispersed: CRM shows a 20.1% operating margin (91st percentile) with $14.4B FCF, while BA's operating margin has been negative in three of the last four quarters and CVS's operating margin sits at just 1.2% with a current ratio below 1.0.

Trade now

This is a watch-list setup, not an active signal — the entry conditions have not triggered across 1,214 evaluated bars over the past 60 months, so the concrete instruction today is to wait. The strategy asks for four things to align simultaneously: price at or below 77.26, price above the 10-period EMA, the 14-period stochastic crossing above zero, and RSI (14) below 45. Only one of those four is currently met for the lower-priced names: RSI (14) is below 45 on BA at 35.2, C at 29.4, CRM at 29.3, CVS at 26.5, UPS at 22.0, and ZTS at 34.4 — but the remaining three conditions are all far from triggering. The structural problem is the entry rule itself. The requirement that the stochastic K line cross above exactly zero is mathematically near-impossible, since stochastic oscillators almost never reach absolute zero before turning up. The second condition — price at or below 77.26 — is met for BSX at 49.28, T at 23.70, and TAL at 12.45, but far from met for BA at 232.15, C at 133.85, CRM at 185.13, and CVS at 96.20. The EMA condition is the closest: several names trade within a few points of their 10-period EMA (BSX is just 0.18 above), but the other conditions block the full stack. Because the rules never fired historically, the stop-loss (2.4 percent), take-profit (4.7 percent), and Fibonacci exit levels are only theoretically active. If an entry somehow triggered, the effective reward-to-risk ratio from the fixed stops is approximately 2:1.…

Scores

• Conviction score breakdown: 30
• Thesis support: 45
• Trade readiness: 15
• Risk quality: 30
• Trigger proximity: 10
• Fundamentals trend: 50

Watch items

• BSX — RSI (14)
• ZTS — Price
• BA — Stochastic (14)
• UPS — Price
• SLB — RSI (14)
• CRM — Price vs EMA (10)
• BA — Price
• BA — Price above EMA (10)
• BA — Stochastic (14) crossed above 0
• BA — RSI (14) below 45